What is the diagnosis and management for a patient with microcytic anemia and significant red blood cell size variation, with lab values indicating low hemoglobin, hematocrit, and MCV?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Iron Deficiency Anemia

This patient has iron deficiency anemia (IDA), confirmed by the combination of severe microcytosis (MCV 70.7), elevated RDW-SD (42.3), and low hemoglobin (11.9 g/dL), which together have 91.4% accuracy for IDA. 1, 2

Immediate Diagnostic Workup

Order serum ferritin and transferrin saturation immediately to confirm iron deficiency before initiating treatment. 1

  • Serum ferritin <30 μg/L confirms iron deficiency in the absence of inflammation 2
  • Ferritin <45 μg/L provides optimal sensitivity and specificity in clinical practice 2
  • Transferrin saturation (TSAT) <15-16% supports iron deficiency and is less affected by inflammation than ferritin 1
  • Check C-reactive protein (CRP) to interpret ferritin in the context of inflammation, as ferritin up to 100 μg/L may still indicate iron deficiency if inflammation is present 3, 1, 2

Why This Is Iron Deficiency and Not Thalassemia

The markedly elevated RDW-SD (42.3) essentially rules out thalassemia trait, which typically presents with low MCV but normal or only slightly elevated RDW. 2, 4 In thalassemia, the RDW is typically ≤14.0%, whereas this patient's RDW is dramatically elevated, reflecting the heterogeneous red cell population characteristic of progressive iron depletion. 1, 2

Investigation for Underlying Blood Loss

All adult men and postmenopausal women with confirmed iron deficiency require gastrointestinal investigation unless there is obvious non-gastrointestinal blood loss. 1

  • Upper endoscopy with small bowel biopsies reveals a cause in 30-50% of patients and is necessary to exclude gastrointestinal malignancy 1
  • Colonoscopy should also be performed to evaluate for lower GI sources of bleeding 1
  • In premenopausal women, consider menstrual blood loss as the primary cause, but still investigate if losses seem excessive or if oral iron fails 2

Treatment Protocol

Start oral ferrous sulfate 200 mg (65 mg elemental iron) three times daily, which is the standard, inexpensive, and well-tolerated first-line treatment. 1, 2

  • Add ascorbic acid (vitamin C) to enhance iron absorption 2
  • Continue treatment for at least 3 months after hemoglobin normalizes to replenish iron stores 2
  • Hemoglobin should rise ≥1 g/dL within 2 weeks, confirming the diagnosis of iron deficiency 2

When to Use Intravenous Iron

Switch to intravenous iron (iron sucrose or iron gluconate) if: 1, 2

  • No response within 2-4 weeks (consider non-compliance or ongoing blood loss first) 2
  • Malabsorption is present 2
  • Gastrointestinal intolerance to oral iron 1
  • Rapid repletion is needed (heart failure, pregnancy) 1

Expect hemoglobin increase of at least 2 g/dL within 4 weeks with intravenous iron. 3, 2

Common Pitfalls to Avoid

  • Do not assume microcytosis equals iron deficiency without confirming with ferritin, as 20-30% of microcytic anemia cases have other diagnoses 5
  • Do not stop iron supplementation when hemoglobin normalizes—continue for 3 months to replenish stores 2
  • Do not overlook ongoing blood loss as the most common cause of treatment failure 2
  • Do not use bone marrow evaluation when serum ferritin and transferrin saturation can establish the diagnosis non-invasively 3, 6

References

Guideline

Diagnosis and Management of Microcytic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Iron Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Investigating iron status in microcytic anaemia.

BMJ (Clinical research ed.), 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.